Related Experiment Video
Updated: Jul 5, 2026

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology
Published on: February 7, 2015
Differential determinants and prognostic value of aortic valve sclerosis over carotid atherosclerosis
Minjeong Kim1, Jiwon Seo2, In-Soo Kim2
1Division of Cardiology, Ewha Womans University Mokdong Hospital, Seoul, Republic of Korea.
Insights
Aortic valve sclerosis (AVS) predicts cardiovascular events and heart failure. However, AVS is a surrogate marker for vascular atherosclerosis and left ventricular dysfunction, not an independent risk factor.
Area of Science:
- Cardiology
- Vascular Biology
- Atherosclerosis Research
Background:
- Aortic valve sclerosis (AVS) is a progressive atherosclerotic disease linked to cardiovascular events (CVE).
- The independence of AVS development and prognostic value from arterial atherosclerosis requires investigation.
- This study evaluates AVS determinants and prognostic value alongside carotid atherosclerosis.
Purpose of the Study:
- To determine the factors influencing aortic valve sclerosis (AVS) development.
- To assess the prognostic significance of AVS for future cardiovascular events (CVE) and heart failure (HF).
- To investigate the relationship between AVS, carotid atherosclerosis, and cardiovascular outcomes.
Main Methods:
- 4688 patients underwent carotid ultrasonography and echocardiography.
- Exclusion criteria included bicuspid aortic valve, rheumatic heart disease, overt aortic stenosis, and prior aortic valve replacement.
- AVS was defined as thickened, hyper-echogenic aortic valve cusps with a peak pressure gradient <2.5 m/s.
Main Results:
- 11% of patients had AVS, independently correlated with age, diabetes, low HDL, and carotid plaques.
- AVS was associated with atherosclerotic CVE (acute coronary syndromes, all-cause death) and future heart failure (HF) admissions.
- AVS predicted atherosclerotic CVE independently of age and sex, but this association was attenuated by carotid plaques. HF admissions were linked to LV systolic and diastolic dysfunction.
Conclusions:
- Aortic valve sclerosis (AVS) is a prognostic marker for future cardiovascular events (CVE) and heart failure (HF).
- Atherosclerotic CVE risk is primarily mediated by vascular atherosclerosis.
- Future HF admissions are mainly driven by left ventricular (LV) systolic and diastolic dysfunction, indicating AVS is a surrogate marker.
Background:
Aortic valve sclerosis (AVS) is a progressive atherosclerotic disease associated with future cardiovascular events (CVE). However, whether its development and prognostic value are independent of arterial atherosclerosis has not been thoroughly investigated. We evaluated the determinants and prognostic value of AVS in conjunction with carotid atherosclerosis.
Methods:
4688 consecutive patients who underwent carotid ultrasonography and echocardiography were followed for an average of 3.6 ± 1.3 years, excluding those with bicuspid aortic valve, rheumatic heart disease, overt aortic stenosis, and prior aortic valve replacement. AVS was defined as any thickened cusps with hyper-echogenicity but a peak pressure gradient <2.5 m/s.
Results:
The mean age of the patients was 61.1 ± 11.7 years, with 1836 (39 %) being women. Among them, 523 (11 %) had AVS. AVS was independently correlated with age, diabetes, lower high-density lipoprotein levels, and presence of carotid plaques. Moreover, it was significantly related to atherosclerotic CVE (acute coronary syndromes, and all-cause death; log-rank p = 0.011) and future heart failure (HF) admissions (p < 0.001). In multivariate analyses, AVS was significantly associated with atherosclerotic CVE regardless of age and sex but significantly attenuated by the presence of carotid plaques. Meanwhile, future HF admission was attenuated considerably after adjusting for E/e' and left ventricular (LV) ejection fraction.
Conclusions:
AVS has prognostic value for future CVE and HF. Atherosclerotic CVE was primarily mediated by vascular atherosclerosis; however, future HF admissions were mainly mediated by concomitant LV systolic and diastolic dysfunction, suggesting that AVS serves as a surrogate marker rather than an independent risk factor.
More Related Videos
04:48Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery
Published on: November 28, 2018
04:30Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation III: Medical Management
Coronary Artery Disease I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Aneurysm II: Clinical Manifestations and Diagnostic Studies